Cargando…

Comparison of Optical Coherence Tomography Biomarkers between Bevacizumab Good Responders and Nonresponders Who were Switched to Dexamethasone Implant in Diabetic Macular Edema

PURPOSE: To compare volumetric optical coherence tomography (OCT) biomarkers in bevacizumab responsive and bevacizumab refractory diabetic macular edema (DME) patients switched to the dexamethasone implant to ultimately identify possible prognostic indicators. METHODS: Retrospective analysis of DME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jeong Hyun, Shin, Joo Young, Ahn, Jeeyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Ophthalmological Society 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151166/ https://www.ncbi.nlm.nih.gov/pubmed/36950923 http://dx.doi.org/10.3341/kjo.2022.0109

Ejemplares similares

One-year outcomes of Aflibercept for refractory diabetic macular edema in Bevacizumab nonresponders
por: Salimi, Ali, et al.
Publicado: (2021)

Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant
por: Herbaut, Antoine, et al.
Publicado: (2017)

Differential systemic gene expression profile in patients with diabetic macular edema: Responders versus nonresponders to standard treatment
por: Dabir, Supriya S, et al.
Publicado: (2014)

Simultaneous Therapy with Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema
por: de ANDRADE, Felipe L., et al.
Publicado: (2016)

Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema
por: Altintas, Ayse Gul Kocak, et al.
Publicado: (2019)

One-year results of switching to aflibercept for persistent diabetic macular edema resistant to bevacizumab
por: Abouhussein, Mahmoud Alaa, et al.
Publicado: (2021)

Initial Dose of Three Monthly Intravitreal Injections versus PRN Intravitreal Injections of Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Ahn, Seong Joon, et al.
Publicado: (2013)

Optical Coherence Tomography Angiography Biomarkers Predict Anatomical Response to Bevacizumab in Diabetic Macular Edema
por: Elnahry, Ayman G, et al.
Publicado: (2022)

Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema
por: Seo, Jeong Won, et al.
Publicado: (2009)

Intravitreal bevacizumab and diabetic papillopathy with macular edema
por: Joob, Beuy, et al.
Publicado: (2012)

Intravitreal injection of Bevacizumab in diabetic macular edema
por: Ateeq, Asim, et al.
Publicado: (2014)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
por: Laine, Ilkka, et al.
Publicado: (2017)

Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Lee, Kyou Ho, et al.
Publicado: (2017)

Identifying responders and nonresponders to interferon therapy in multiple sclerosis
por: Prosperini, Luca, et al.
Publicado: (2014)

Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: A case report
por: Sharma, Ashish, et al.
Publicado: (2012)

Diabetic papillopathy with macular edema treated with intravitreal bevacizumab
por: Al-Hinai, Ahmed S., et al.
Publicado: (2011)

Diabetic papillopathy with macular edema treated with intravitreal bevacizumab
por: Al-Hinai, Ahmed S.
Publicado: (2012)

Resolution of macular edema in Coats' disease with intravitreal bevacizumab
por: Entezari, Morteza, et al.
Publicado: (2010)

Optical coherence tomography and imaging biomarkers as outcome predictors in diabetic macular edema treated with dexamethasone implant
por: Chou, Hung-Da, et al.
Publicado: (2022)

Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema After Dexamethasone Implants
por: Huang, Yu-Te, et al.
Publicado: (2022)

Differentiation between Good and Low-Responders to Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion
por: Menke, Marcel N., et al.
Publicado: (2016)

Short‐term GAA loading: Responders versus nonresponders analysis
por: Ostojic, Sergej M.
Publicado: (2020)

Optical coherence tomography patterns of diabetic macular edema and treatment response to bevacizumab: a short-term study
por: Sharma, Sadhana, et al.
Publicado: (2022)

Dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Dugel, Pravin U, et al.
Publicado: (2015)

Widening use of dexamethasone implant for the treatment of macular edema
por: Bonfiglio, Vincenza, et al.
Publicado: (2017)

Intravitreal Bevacizumab Alone versus Combined with Macular Photocoagulation in Diabetic Macular Edema
por: Lee, Soo Jeong, et al.
Publicado: (2011)

Macular Hole Formation after Intravitreal Injection of Bevacizumab for Diabetic Macular Edema
por: Lee, Yun Ji, et al.
Publicado: (2019)

Adaptive differentiation of murine lymphocytes. IV. (Responder × Nonresponder) F(1) T cells can be taught to preferentially help nonresponder,rather than responder, B cells
por: Katz, DH, et al.
Publicado: (1979)

Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections
por: Shin, Yong Un, et al.
Publicado: (2017)

Optical coherence tomography biomarkers in patients with macular edema secondary to retinal vein occlusion treated with dexamethasone implant
por: Castro-Navarro, Verónica, et al.
Publicado: (2022)

The Effects of Intravitreal Bevacizumab in Infectious and Noninfectious Uveitic Macular Edema
por: Al-Dhibi, Hassan, et al.
Publicado: (2014)

Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates
por: Jeon, Sohee, et al.
Publicado: (2014)

Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab
por: Lim, Laurence S, et al.
Publicado: (2015)

Primary Effects of Intravitreal Bevacizumab in Patients with Diabetic Macular Edema
por: Tareen, Iftikhar-ul-Haq, et al.
Publicado: (2013)

Effect of Adding Losartan to Bevacizumab for Treating Diabetic Macular Edema
por: Ghassemi, Fariba, et al.
Publicado: (2020)

Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant
por: Baillif, Stéphanie, et al.
Publicado: (2022)

Distinctively different predictors for long‐term outcomes between responders and nonresponders who underwent cardiac resynchronization therapy
por: Yufu, Kunio, et al.
Publicado: (2020)

Preliminary Study of Different Treatment Responses between Bevacizumab, Aflibercept and Dexamethasone Implant According to Renal Function in Diabetic Macular Edema Patients
por: Moon, Tae Hwan, et al.
Publicado: (2022)

Combined intravitreal dexamethasone and bevacizumab injection for the treatment of persistent diabetic macular edema (DexaBe study): a phase I clinical study
por: Veiga Reis, Francyne, et al.
Publicado: (2023)

Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β
por: Bustamante, Marta F., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mp226mobokjt48op9to1tubseo